<DOC>
	<DOCNO>NCT00250380</DOCNO>
	<brief_summary>The purpose study determine clinically meaningful definition prevalence aspirin resistance base data link aspirin-dependent laboratory test recurrent vascular event cardiovascular patient take aspirin .</brief_summary>
	<brief_title>The Study Profile Genetic Factors Aspirin Resistance ( ProGEAR Study )</brief_title>
	<detailed_description>Primary Outcomes : The primary endpoint composite outcomes cerebral infarction , transient ischemic attack , myocardial infarction , unstable angina , percutaneous coronary angiography , thromboembolism , death cause cardiovascular disease . Secondary Outcomes : Platelet aggregation induce collagen arachidonic acid , serum thromboxane B2 , urine 11-dehydrothromboxane B2 , platelet thrombus formation flow condition ( sub-study National Cardiovascular Center ) The primary objective study determine marker aspirin resistance . To achieve objective , platelet aggregation , serum thromboxane B2 , urine 11-dehydrothromboxane B2 measure patient receive usual therapeutic dos aspirin , experience acute coronary syndrome , cerebral infarction , transient ischemic attack occur period past 1 month past 2 year . This multi-center , prospective study .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Adult male female meet criterion list : Patients acute coronary syndrome , cerebral infarction ( except cardioembolic stroke ) , transient ischemic attack past 28 day past 2 year patient receive longterm aspirin therapy ( least 28 day ) Patients &gt; =20 year age Patients willing able give write informed consent Malignancy suspect malignancy Patients show platelet count le 100,000/uL 450,000/uL Congenital bleeding tendency Patients receive antiplatelet drug warfarin Patients atrial fibrillation Patients receive surgical operation catheter intervention within past 2 week Patients received anticoagulation drug therapy include heparin ( lowmolecular weight heparin ) danaparoid . Patients modify Rankin scale 4</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
</DOC>